BlackRock Capital Allocation Term Trust (NYSE:BCAT) Short Interest Update

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totaling 2,523,119 shares, a growth of 84.2% from the August 31st total of 1,369,920 shares. Approximately 2.4% of the shares of the stock are short sold. Based on an average trading volume of 1,213,487 shares, the days-to-cover ratio is presently 2.1 days.

BlackRock Capital Allocation Term Trust Price Performance

Shares of BCAT stock traded up $0.04 during trading hours on Wednesday, hitting $13.71. 1,272,532 shares of the company’s stock were exchanged, compared to its average volume of 773,790. BlackRock Capital Allocation Term Trust has a 52 week low of $13.43 and a 52 week high of $16.20. The stock’s 50-day moving average is $15.40 and its 200-day moving average is $15.32.

BlackRock Capital Allocation Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Stockholders of record on Friday, December 11th will be given a dividend of $0.2501 per share. The ex-dividend date is Friday, December 11th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 21.9%.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Several hedge funds have recently added to or reduced their stakes in BCAT. Bank of America Corp DE bought a new stake in BlackRock Capital Allocation Term Trust during the 2nd quarter worth about $24,720,000. Keebeck Wealth Management acquired a new position in BlackRock Capital Allocation Term Trust during the 2nd quarter valued at about $5,607,000. Royal Bank of Canada boosted its stake in shares of BlackRock Capital Allocation Term Trust by 50.2% in the 1st quarter. Royal Bank of Canada now owns 570,035 shares of the company’s stock valued at $8,055,000 after purchasing an additional 190,604 shares during the last quarter. Perennial Investment Advisors LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at about $1,826,000. Finally, Formidable Asset Management LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust during the 1st quarter worth approximately $933,000. Institutional investors own 36.12% of the company’s stock.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a diversified, closed-end management investment company advised by BlackRock Advisors, LLC. The fund seeks to provide total return through a combination of current income and capital appreciation.

BCAT invests across both equity and debt markets. Its portfolio may include common stocks, preferred securities, convertible securities, investment-grade and below-investment-grade corporate bonds, loans, and other fixed-income instruments.

Further Reading

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.